In tamoxifen-resistant LCC9 breast cancer cells, studies have determined that overexpressed m6A “reader” HNRNPA2B1 can upregulate and downregulate different miRNAs simultaneously and affect the downstream signalling pathways of these miRNAs. Here, HNRNPA2B1 is linked to breast carcinoma.